Image-guided treatment could lead to increased libido in women

Uterine fibroid embolization (UFE), a nonsurgical, image-guided treatment of uterine fibroids may lead to improved sexual function and higher overall quality of life for female patients, according to research recently presented at the Society of Interventional Radiology's Annual Scientific Meeting in Vancouver.

The procedure, which is used to treat the common condition of fibroids developing in the muscular wall of the uterus, employs the insertion of a catheter into the patient’s relevant artery to provide real-time imaging and treatment administration, causing the fibroid tumors to shrink and eventually die.

The researchers performed a retrospective study on 264 patients who underwent UFE for benign fibroid tumors, asking them to complete a quality-of-life questionnaire approximately one-year following treatment.

The results showed that nearly 80 percent of respondents reported significant improvements in sexual function in terms of overall pain, desire, arousal and satisfaction, with the vast majority of women experiencing sustained improvement for more than a year following UFE.

"Women with uterine fibroids often experience troubling symptoms and significant discomfort, which diminish their sex lives and reduce their quality of life. These symptoms include heavy menstrual bleeding, pain during sexual intercourse, pelvic pain and back and leg pain," said lead author Helene Vernhet-Kovacsik, MD, of vascular radiology at Centre Hospitalier Universitaire, Montpellier in France. "Working in collaboration with a patient's gynecologist, interventional radiologists can now offer these women a treatment option which alleviates chronic pain within the female reproductive system and allows the opportunity to lead a full and more normal life.”

Read the presentation abstract here.

 

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup